# enVVeno Medical Corp: Form SCHEDULE 13D, filed Feb 20, 2026

- Company: [enVVeno Medical Corp](/companies/nvno.md) (CIK 1661053)
- Form: SCHEDULE 13D
- Filed: 2026-02-20
- Accepted by EDGAR: Feb 20, 2026, 09:43 ET
- Period: not reported
- Accession: 0001213900-26-018625
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1661053/000121390026018625/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1661053/000121390026018625/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1661053/000121390026018625/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-018625. Last ingested by Listed: Nov 10, 2026, 21:11 ET. No prices; not investment advice.
